|
| [May 29, 2008] |
 |
Thermo Fisher Scientific to Showcase New Mass Spectrometry Systems, Software and Workflow Solutions at ASMS 2008
DENVER, Colo. --(Business Wire)-- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the introduction of a wide range of mass spectrometry technologies that deliver new levels of analytical performance for a wide range of applications, from advanced life sciences research to routine compound screening. The expanded Thermo Scientific mass spectrometry portfolio will be showcased at the 56th ASMS Conference on Mass Spectrometry and Allied Topics, taking place in Denver from June 1-5.
"We have made significant technical advances across our entire mass spectrometry portfolio," noted Dr. Ian Jardine, vice president of global research and development for Thermo Fisher Scientific. "At ASMS we are highlighting the latest additions to our leading portfolio and demonstrating how these new products can enable scientists to reach new heights of performance, whether they need highly sensitive protein quantitation, or fast, simple compound identification."
Featured breakthrough technologies at ASMS include:
Thermo Scientific TSQ Vantage(TM) Triple Quadrupole - This most recent addition to the popular line of TSQ triple quadrupole mass spectrometers delivers up to 10 times more sensitivity than competing systems. Innovative new ion optics and ion-source technology transmit virtually every ion to the mass analyzer, delivering unmatched signal-to-noise performance for reproducible and precise quantitative analysis of small molecules, biomolecules and peptides.
Thermo Scientific Exactive(TM) LC-MS - Leveraging the proven performance of Orbitrap(TM) technology, Exactive provides sub-ppm mass accuracy at resolutions of up to 100,000 for routine compound screening and identification. With intuitive software, this new benchtop LC-MS system is easy for non-specialists to operate in "walk-up" mode, yet delivers the high resolution, sensitivity and mass accuracy needed for the most challenging analytical work.
Thermo Scientific Proteome Discoverer Software - This new proteomics analysis software platform provides researchers with a comprehensive view of quantitative and qualitative proteomic data by combining and comparing data from multiple search engines, public databases and dissociation methods. It allows data mining on a much larger scale than has previously been possible, yet is flexible and easy to use.
The company will also debut Thermo Scientific TMT(R) Tags, an exclusive labeling technology for multiplexed global protein quantitation. This isobaric mass tagging chemistry enables identification and quantitation of protein expression levels from multiple samples including cells, tissues and biological fluids. The unique and consistent chemistry of TMT Tags allow for efficient transition from method development to multiplex quantitation, leading to increased throughput for accelerated biomarker discovery.
For more information on new Thermo Scientific mass spectrometry technology, please visit booth 41 at ASMS. For full press releases announcing all new products at ASMS 2008, please visit www.thermo.com/ASMS.
Thermo Scientific is part of Thermo Fisher Scientific, the world leader in serving science.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With annual revenues of $10 billion, we have more than 30,000 employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit www.thermofisher.com.
The following constitutes a "Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the company's Quarterly Report on Form 10-Q for the quarter ended March 29, 2008, under the caption "Risk Factors," which is on file with the Securities and Exchange Commission (SEC) and available in the "Investors" section of our Website under the heading "SEC Filings." Important factors that could cause actual results to differ materially from those indicated by forward-looking statements include risks and uncertainties relating to: the risk that the legacy businesses of Thermo Electron Corporation ("Thermo") and Fisher Scientific International Inc. ("Fisher") will not be integrated successfully; the risk that the cost savings and any other synergies from the merger of Thermo and Fisher may not be fully realized or may take longer to realize than expected; competition and its effect on pricing, spending, third-party relationships and revenues; the need to develop new products and adapt to significant technological change; implementation of strategies for improving internal growth; use and protection of intellectual property; dependence on customers' capital spending policies and government funding policies; realization of potential future savings from new productivity initiatives; general worldwide economic conditions and related uncertainties; the effect of changes in governmental regulations; the effect of exchange rate fluctuations on international operations; the effect of laws and regulations governing government contracts; the effect of competing with certain of our customers and suppliers; and the effect of rapid changes in the healthcare industry. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our estimates change and, therefore, you should not rely on these forward-looking statements as representing our views as of any date subsequent to today.
[ Back To SIP Trunking Community's Homepage ]
|
